| answer text |
<p>The Department welcomes the recently announced TRANSFORM trial which aims to save
thousands of men each year by finding the best way to screen for prostate cancer across
all ethnic groups. It will be spread across the United Kingdom, although final decisions
on specific locations are yet to be taken. Men will be invited to participate via
their general practices. This study, led by Prostate Cancer UK and supported by the
Government among others, will also aim to address some of the inequalities that exist
in prostate cancer diagnosis today by ensuring that one in ten of the trial participants
will be black men, who are three times overrepresented compared to the population
of men aged between 45 and 75 years old as based on 2021 census data.</p><p> </p><p>More
broadly, the National Institute for Health and Care Research (NIHR) funds research
in response to proposals received from scientists and commissioned calls rather than
allocating funding to specific disease areas. It welcomes funding applications for
research into any aspect of human health, including prostate cancer. Applications
are subject to peer review and judged in open competition, with awards being made
based on the importance of the topic to patients and health and care services, value
for money and scientific quality.</p><p> </p><p>In addition, to raise awareness of
prostate cancer in this group, Leicester’s Centre for BME Health has developed a toolkit
in partnership with the NIHR with guidance on how to start conversations about prostate
cancer and overcome barriers to diagnosis.</p>
|
|
